Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib and Pemetrexed Maintenance in EGFR-Negative NSCLC
NCT01579630Phase 3Unknown
- Sponsor
- Taipei Veterans General Hospital
- Start
- Mar 2011
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gefitinib in Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC), sponsored by Taipei Veterans General Hospital. Status: unknown.
02
Drugs
03
Conditions
Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC)
Beyond the preview
Go deeper on NCT01579630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01579630.